An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ACL ALU ASX (2) BCI (2) DUB ECF EVS GCY HSN IKE LRK LYL MYX NAB OSL PPE QUB
ACL
Healthcare services - Overnight Price:
Goldman Sachs rates ((ACL)) as Initiation of coverage with Buy (1) -
Goldman Sachs initiates coverage on
Goldman Sachs expects the company to benefit from a series of operational investments, with the broker highlighting investment in a unified Laboratory Information System and an upgraded central laboratory network as of particular interest.
Further, the broker points to forecast longer-term growth around the market of around 3-5% depending on how the company executes on growth strategies in
Goldman Sachs initiates with a Buy rating and a target price of
This report was published on
Target price is
If ACL meets the Goldman Sachs target it will return approximately 38% (excluding dividends, fees and charges).
Forecast for FY21:
Goldman Sachs forecasts a full year FY21 dividend of 0.00 cents and EPS of 42.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.31.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 dividend of 10.00 cents and EPS of 17.00 cents.
At the last closing share price the estimated dividend yield is 2.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.53.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ALU
Hardware & Equipment - Overnight Price:
Altium announced that Autodesk, a US-listed multi-national software company, has proposed an offer for the company valued at
The broker views the offer as opportunistic given the depressed earnings base due to covid and the depressed multiple versus peers. Additionally, it's thought the price merely reflects historical trading ranges, rather than including a premium for synergies.
The analyst feels downside is limited and there is a reasonable chance of a revised offer from Autodesk, or even a competing bid from private equity or other trade buyers.
This report was published on
Target price is
If ALU meets the
Current consensus price target is
The company's fiscal year ends in June.
Forecast for FY21:
Shaw and Partners forecasts a full year FY21 dividend of 73.46 cents and EPS of 46.43 cents.
At the last closing share price the estimated dividend yield is 2.03%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 78.08.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 44.9, implying annual growth of N/A.
Current consensus DPS estimate is 43.4, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 80.7.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 77.87 cents and EPS of 52.58 cents.
At the last closing share price the estimated dividend yield is 2.15%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 68.94.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 54.0, implying annual growth of 20.3%.
Current consensus DPS estimate is 46.6, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 67.1.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ASX
Wealth Management & Investments - Overnight Price:
Goldman Sachs rates ((ASX)) as Sell (5) -
Goldman Sachs assesses a slight increase in average daily contracts traded (versus
The May trading update revealed recent soft trends across products continued, points out the broker. While daily average volumes were down -16% and -6% on the pcp for 90-day bank bills and 3-year bonds, volumes in the 10-year bond product were up 17% on the pcp.
Meanwhile, OTC cleared value is tracking -81% below the pcp.
This report was published on
Target price is
If ASX meets the Goldman Sachs target it will return approximately minus 13% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is
The company's fiscal year ends in June.
Forecast for FY21:
Goldman Sachs forecasts a full year FY21 EPS of 249.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.02.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 246.5, implying annual growth of -4.3%.
Current consensus DPS estimate is 223.9, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 31.3.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 EPS of 246.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.40.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 251.6, implying annual growth of 2.1%.
Current consensus DPS estimate is 225.9, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 30.7.
Market Sentiment: -0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Jarden rates ((ASX)) as Initiation of coverage with Underweight (2) -
Jarden initiates coverage on
Jarden notes post-FY21 a weaker cash equity outlook could contribute to earnings per share compound annual growth rate being constrained to 4.8% over the next three years.
The anticipated earnings per share decrease is notably the largest decline since FY09 which was impacted by the Global Financial Crisis.
ASX's largest segment, Derivative Revenues, is expected to fall -13% in FY21, but Jarden suggests that while volumes should bottom out in FY21, a 12% increase is predicted for FY22 and a 9-10% increase for FY23 through FY24.
Jarden initiates with an Underweight rating and a target price of
This report was published on
Target price is
If ASX meets the Jarden target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is
The company's fiscal year ends in June.
Forecast for FY21:
Jarden forecasts a full year FY21 dividend of 229.90 cents and EPS of 245.80 cents.
At the last closing share price the estimated dividend yield is 2.98%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.42.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 246.5, implying annual growth of -4.3%.
Current consensus DPS estimate is 223.9, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 31.3.
Forecast for FY22:
Jarden forecasts a full year FY22 dividend of 241.10 cents and EPS of 255.50 cents.
At the last closing share price the estimated dividend yield is 3.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 30.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 251.6, implying annual growth of 2.1%.
Current consensus DPS estimate is 225.9, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 30.7.
Market Sentiment: -0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BCI
Iron Ore - Overnight Price:
Via lower shareholder dilution alone, the broker estimates a 50% increase in the company's valuation. The broker raises the EPS forecast for FY21 to 8.6cps from 5.9cps, FY22 to 7.8cps from 2.8cps and FY23 to 1.5cps from 1.1cps.
Buy rated and target rises to
This report was published on
Target price is
If BCI meets the Bell Potter target it will return approximately 23% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Bell Potter forecasts a full year FY21 dividend of 0.00 cents and EPS of 8.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.51.
Forecast for FY22:
Bell Potter forecasts a full year FY22 dividend of 0.00 cents and EPS of 8.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.29.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
A recent site visit to the Mardie Salt and SOP project' reinforced to the broker that early works are well underway (40 people onsite, civils commenced) and long-lead-time items ordered. It's felt the salt price is grinding higher, with the most recent prices in the
The analyst assesses the capital burden (
This report was published on
Target price is
If BCI meets the
The company's fiscal year ends in June.
Forecast for FY21:
Canaccord Genuity forecasts a full year FY21 EPS of 4.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.00.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 EPS of 2.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
DUB
Cloud services - Overnight Price:
The program to be launched will be known as Dubber Go, a product with a go to market strategy that enables users across a range of managed service providers, telcos, carriers and providers.
The Buy rating is retained and the target price increases to
This report was published on
Target price is
If DUB meets the
The company's fiscal year ends in June.
Forecast for FY21:
Shaw and Partners forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 4.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 67.33.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 3.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 77.69.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ECF
REITs - Overnight Price:
The fund portfolio proved to be resilient to covid impacts through 2020.
The broker notes the Australian commercial real estate market remains attractive, and has initiated coverage based on market conditions combined with high capital growth potential from active portfolio management. The broker feels these attributes are not currently reflected in the share price.
This report was published on
Target price is
If ECF meets the
The company's fiscal year ends in June.
Forecast for FY21:
Shaw and Partners forecasts a full year FY21 dividend of 10.10 cents and EPS of 12.60 cents.
At the last closing share price the estimated dividend yield is 8.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.21.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 10.20 cents and EPS of 12.80 cents.
At the last closing share price the estimated dividend yield is 8.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.06.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
EVS
Industrial Sector Contractors & Engineers - Overnight Price:
A capital raising of around
After a trading update,
The rating is upgraded to Buy (Speculative) from Hold and the target falls to
This report was published on
Target price is
If EVS meets the Bell Potter target it will return approximately 67% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Bell Potter forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 1.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 6.92.
Forecast for FY22:
Bell Potter forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 18.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
GCY
Gold & Silver - Overnight Price:
Adverse weather events, increased ore processed with an elevated sulphide content and resourcing challenges will result in output reducing quarter-on-quarter. The company indicated lower production has led to slightly increased all-in-sustaining costs (AISC).
The analyst notes the AISC guidance range for FY22 has been revised to
The Buy rating is unchanged and the target price drops to
This report was published on
Target price is
If GCY meets the
The company's fiscal year ends in June.
Forecast for FY21:
Canaccord Genuity forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 11.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 2.91.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of 7.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.57.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
HSN
IT & Support - Overnight Price:
The analyst considers it a fair and reasonable price for the business.
This report was published on
Target price is
If HSN meets the
The company's fiscal year ends in June.
Forecast for FY21:
Shaw and Partners forecasts a full year FY21 dividend of 10.00 cents and EPS of 35.60 cents.
At the last closing share price the estimated dividend yield is 1.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.58.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 10.00 cents and EPS of 25.90 cents.
At the last closing share price the estimated dividend yield is 1.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.17.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IKE
Hardware & Equipment - Overnight Price:
ikeGPS Group's FY21 results proved largely in line with
A year-on-year decline in revenue was driven by the deferral of planned works by a number of customers. The company has secured around NZ$8.8m in new contracts, with the majority of these to be realised in FY22 and accounting for around 58.6% of FY22 revenue forecast. Bell Potter considers the company well-placed for continued contract wins.
The broker notes ikeGPS Group is one of the only companies on the ASX and NZX leveraged to the rollout of 5G infrastructure in
The Buy rating and target price of
This report was published on
Target price is
If IKE meets the Bell Potter target it will return approximately 21% (excluding dividends, fees and charges).
The company's fiscal year ends in March.
Forecast for FY22:
Bell Potter forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 3.63 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 30.85.
Forecast for FY23:
Bell Potter forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 1.49 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 75.22.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LRK
Food, Beverages & Tobacco - Overnight Price:
Moelis rates ((LRK)) as Buy (1) -
Moelis runs some scenario analysis to illustrate potential upside to the broker's earnings estimates and valuation, should the company achieve better-than-expected net sales values. This would derive from the successful execution of a number of strategic initiatives.
For example, assuming a net sales value of
For now, the broker makes no changes to estimates for Lark Distilling Co. The Buy rating is maintained and the price target increased to
The report was published on
Target price is
If LRK meets the Moelis target it will return approximately 2% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Moelis forecasts a full year FY21 dividend of 0.00 cents and EPS of 1.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 319.00.
Forecast for FY22:
Moelis forecasts a full year FY22 dividend of 0.00 cents and EPS of 6.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 51.45.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LYL
Mining Sector Contracting - Overnight Price:
The Buy rating and target price of
This report was published on
Target price is
If LYL meets the Bell Potter target it will return approximately 21% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Bell Potter forecasts a full year FY21 dividend of 20.00 cents and EPS of 30.20 cents.
At the last closing share price the estimated dividend yield is 3.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.72.
Forecast for FY22:
Bell Potter forecasts a full year FY22 dividend of 30.00 cents and EPS of 42.50 cents.
At the last closing share price the estimated dividend yield is 5.61%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.59.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MYX
Pharmaceuticals & Biotech/Lifesciences - Overnight Price:
It provides significantly better control for unscheduled bleeding/spotting and is likely to have fewer other side effects including weight gain and hemostatis, explains the broker.
Buy rating and target price of
This report was published on
Target price is
If MYX meets the Bell Potter target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is
The company's fiscal year ends in June.
Forecast for FY21:
Bell Potter forecasts a full year FY21 dividend of 0.00 cents and EPS of 1.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.63.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -0.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY22:
Bell Potter forecasts a full year FY22 dividend of 0.00 cents and EPS of 1.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.57.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -0.4, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NAB
Banks - Overnight Price:
Goldman Sachs rates ((NAB)) as Buy (1) -
AUSTRAC has stated that it is not considering civil penalty proceedings at this stage, and decisions about enforcement action have not yet been made.
Goldman Sachs notes the announcement should be considered in context of penalties given to
The Buy rating is retained and the target price increases to
This report was published on
Target price is
If NAB meets the Goldman Sachs target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is
The company's fiscal year ends in September.
Forecast for FY21:
Goldman Sachs forecasts a full year FY21 EPS of 185.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.08.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 192.2, implying annual growth of 134.0%.
Current consensus DPS estimate is 122.5, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 13.5.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 EPS of 185.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.08.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 189.6, implying annual growth of -1.4%.
Current consensus DPS estimate is 130.5, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 13.7.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
OSL
Pharmaceuticals & Biotech/Lifesciences - Overnight Price:
Wilsons rates ((OSL)) as Overweight (1) -
Australian regulators have required a higher level of evidence than other jurisdictions and the application is unlikely to be reopened until further comparative data are available.
Key for the company now is a potential Humanitarian Device Exemption. This clearance holds more immediate revenue potential and offers a lower evidence hurdle to clinical adoption. Wilsons notes
The Overweight rating and target price of
This report was published on
Target price is
If OSL meets the Wilsons target it will return approximately 317% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Wilsons forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 1.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 4.29.
Forecast for FY22:
Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 1.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 4.62.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PPE
Jobs & Skilled Labour Services - Overnight Price:
Moelis rates ((PPE)) as Downgrade to Hold from Buy (3) -
Moelis reports
The broker also highlights that with over
The rating is downgraded to Hold and the target price increases to
This report was published on
Target price is
If PPE meets the Moelis target it will return approximately 8% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Moelis forecasts a full year FY21 dividend of 9.90 cents and EPS of 25.70 cents.
At the last closing share price the estimated dividend yield is 2.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.12.
Forecast for FY22:
Moelis forecasts a full year FY22 dividend of 14.70 cents and EPS of 29.30 cents.
At the last closing share price the estimated dividend yield is 3.34%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.02.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
QUB
Jarden rates ((QUB)) as Buy (1) -
Despite the repayment of
Year-on-year container volume growth of 20.1% across
The broker forecasts revenue growth for the Operating Division of 9.6% in the second half, around 11% lower than forecasted container volume growth. Jarden notes this suggests some upside risks to forecasts.
The Buy rating and target price of
This report was published
Target price is
If QUB meets the Jarden target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is
The company's fiscal year ends in June.
Forecast for FY21:
Jarden forecasts a full year FY21 dividend of 5.60 cents and EPS of 5.70 cents.
At the last closing share price the estimated dividend yield is 1.78%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 55.09.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.9, implying annual growth of 32.2%.
Current consensus DPS estimate is 5.2, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 45.5.
Forecast for FY22:
Jarden forecasts a full year FY22 dividend of 5.70 cents and EPS of 6.20 cents.
At the last closing share price the estimated dividend yield is 1.82%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 50.65.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.4, implying annual growth of 21.7%.
Current consensus DPS estimate is 5.9, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 37.4.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are
Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.
All material published by
© 2021 Acquisdata Pty Ltd., source